Annual report pursuant to Section 13 and 15(d)

Statements of Changes in Stockholders' Equity

v3.20.1
Statements of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 61 $ 24,389,307 $ (35,519,819) $ (11,130,451)
Balance, shares at Dec. 31, 2017 6,133,678      
Common stock issued in initial public offering [1] $ 17 6,082,427 6,082,444
Common stock issued in initial public offering, shares [1] 1,725,000      
Derivative liabilities reclassified to equity 3,594,002 3,594,002
Redeemable convertible preferred stock converted to common stock $ 18 5,170,737 5,170,755
Redeemable convertible preferred stock converted to common stock, shares 1,743,231      
Common stock issued in connection with May Bridge Notes $ 1 228,965 228,966
Common stock issued in connection with May Bridge Notes, shares 55,000      
Common stock issued in satisfaction of Advisory Board fees payable 90,000 90,000
Common stock issued in satisfaction of Advisory Board fees payable, shares 30,000      
Common stock issued upon conversion of convertible debt and interest $ 17 8,252,669 8,252,686
Common stock issued upon conversion of convertible debt and interest, shares 1,650,537      
Common stock issued upon conversion of related party convertible debt and interest $ 1 517,741 517,742
Common stock issued upon conversion of related party convertible debt and interest, shares 120,405      
Common stock issued upon exchange of related party notes payable and interest 150,553 150,553
Common stock issued upon exchange of related party notes payable and interest, shares 35,012      
Common stock issued in satisfaction of deferred salary 200,000 200,000
Common stock issued in satisfaction of deferred salary, shares 44,444      
Stock-based compensation: Amortization of stock options 864,625 864,625
Stock-based compensation: Common stock issued to consultants/settlement, net $ 2 878,828 878,830
Stock-based compensation: Common stock issued to consultants/settlement, net, shares 185,340      
Stock-based compensation: Warrants granted to consultants/settlement 179,000 179,000
Net loss (13,042,709) (13,042,709)
Balance at Dec. 31, 2018 $ 117 50,598,854 (48,562,528) 2,036,443
Balance, shares at Dec. 31, 2018 11,722,647      
Common stock issued in initial public offering [2] $ 36 3,319,620 3,319,656
Common stock issued in initial public offering, shares [2] 3,615,622      
Stock-based compensation: Common stock issued to consultants/settlement, net [3] $ 2 419,377 419,379
Stock-based compensation: Common stock issued to consultants/settlement, net, shares [3] 235,863      
Stock-based compensation: Warrants granted to consultants/settlement 30,499 30,499
Stock-based compensation: Amortization of stock options and restricted stock units [4] 492,084 492,084
Stock-based compensation: Amortization of stock options and restricted stock units, shares [4] 9,728      
Common stock issued in private placement offering [5] $ 24 2,317,252 2,317,276
Common stock issued in private placement offering, shares [5] 2,347,997      
Net loss (7,625,397) (7,625,397)
Balance at Dec. 31, 2019 $ 179 $ 57,177,686 $ (56,187,925) $ 989,940
Balance, shares at Dec. 31, 2019 17,931,857      
[1] net of offering costs of $2,542,555
[2] net of offering costs of $549,060.
[3] net of forfeiture of 6,137 shares.
[4] stock issued for vested restricted stock units.
[5] net of offering costs of $386,724.